Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.

Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.

Item
http://www.wikidata.org/entity/Q50690986
High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancerAdjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patientsLong-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation.Filling in the gaps: reporting of concurrent supportive care therapies in breast cancer chemotherapy trials.Metronomic chemotherapy enhances antitumor effects of cancer vaccine by depleting regulatory T lymphocytes and inhibiting tumor angiogenesisIs Higher Efficacy Always at the Price of More Side Effects during Chemotherapy?High-dose chemotherapy followed by autologous stem cell transplantation as a first-line therapy for high-risk primary breast cancer: a meta-analysis.High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancer.Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy.Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapyBreast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic reviewCritical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients.High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast Cancer.Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.Breast cancer (non-metastatic).Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?
P2860

Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.

Item
http://www.wikidata.org/entity/Q50690986
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Intensive dose-dense compared ...... y Group/Intergroup study 9623.
@en
Intensive dose-dense compared ...... y Group/Intergroup study 9623.
@nl
type
label
Intensive dose-dense compared ...... y Group/Intergroup study 9623.
@en
Intensive dose-dense compared ...... y Group/Intergroup study 9623.
@nl
prefLabel
Intensive dose-dense compared ...... y Group/Intergroup study 9623.
@en
Intensive dose-dense compared ...... y Group/Intergroup study 9623.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Intensive dose-dense compared ...... y Group/Intergroup study 9623.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921